Amide protein transfer weighted (APTw) MRI has been validated to accurately detect recurrent malignant gliomas across different studies. However, APTw image interpretation is time consuming and requires professional knowledge. Therefore, reliable, automated imaging diagnostic tools to assess malignant glioma response to therapies are urgently needed. Here, we develop and verify a CNN-based deep-learning algorithm to identify tumor progression versus response by adding APTw MRI data to structural MR images as the proposed model input. Our results suggest that the use of APTw images can increase the diagnostic accuracy to structural MRI for the treatment response assessment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords